Taking on one of the toughest diseases
Six million Americans are living with Alzheimer’s Disease, and that number is projected to soar to 14 million by 2050.
The Keck School has four world-renowned research centers and institutes focused on this devastating disease. Taking a multi-angled approach – from basic research on the earliest molecular changes that lead to cognitive decline to clinical trials of innovative treatments to slow or prevent the disease’s progression – the Keck School of Medicine of USC is at the forefront of the hunt for effective treatments.
Alzheimer’s Video Series
Leading the charge on new treatments: The Alzheimer’s Therapeutic Research Institute (ATRI) at USC
The Alzheimer’s Therapeutic Research Institute (ATRI) at USC is at the forefront of bringing effective new treatments for Alzheimer’s disease to the world through rigorous clinical trial design and the identification of reliable biomarkers for early detection of the disease – long before cognitive decline occurs.
With cutting-edge imaging and information technologies, and one of the largest global data networks in the world, the USC Mark and Mary Stevens Neuroimaging and Informatics Institute is accelerating the pace of discovery in Alzheimer’s disease by leveraging imaging and big data to reveal what was impossible to perceive before.
Cutting-edge Alzheimer’s research and care: USC Neurology/Alzheimer’s Disease Research Center.
In the hunt for innovative treatments for Alzheimer’s disease, the Keck School of Medicine of USC’s Department of Neurology, home to the USC’s Alzheimer’s Disease Research Center, is working to bring the latest discoveries to patients and their families.
Targeting the earliest signs of Alzheimer’s disease: The Zilkha Neurogenetic Institute
The Zilkha Neurogenetic Institute is pursuing new treatments for Alzheimer’s disease that could stop the disease process long before cognitive decline begins – treatments which would target early problems in the brain’s vascular system that may lead to dementia.
Centers & Institutes
The Alzheimer Disease Research Center at USC (ADRC) works to understand the biological changes that may precede worsening memory and to assess whether new treatments, including drugs, may be helpful in preventing memory or delay memory loss.
USC’s Mark and Mary Stevens Neuroimaging and Informatics Institute (USC Stevens INI) applies innovative imaging and information technologies to the study of the brain. We share our data and resources with thousands of collaborators around the world.
The mission of the Alzheimer’s Therapeutic Research Institute (ATRI) is to rigorously test methods for early detection of, and treatments for Alzheimer’s disease (AD) and bring effective therapeutics to the world.
The Zilkha Neurogenetic Institute (ZNI) is a cross-disciplinary hub for the neuroscience community at USC. At Zilkha, we conduct world-class science in state-of-the-art labs.
Learn More About Our Work
The MBPH program is an inter-campus program that includes faculty from all over USC who not only have active biophysical research programs and serve as mentors, but also contribute to courses offered by the program.
Prepare for a rewarding career in biomedicine. Join the USC Mark and Mary Stevens Neuroimaging and Informatics Institute’s premier one-year degree program on brain imaging and the associated informatics.